Key result
Over 14 years, 19% of type 1 diabetes patients died and 18% developed CAD; renal impairment and retinopathy strongly predicted mortality, while abnormal lipoprotein metabolism predicted CAD.
Why the study?
What are the long-term clinical and biochemical predictors of mortality and coronary artery disease in patients with type 1 diabetes mellitus?
Cohort (n=147)
What are the long-term clinical and biochemical predictors of mortality and coronary artery disease in patients with type 1 diabetes mellitus?
In patients with type 1 diabetes, abnormal lipoprotein metabolism strongly predicts coronary artery disease, whereas indicators of renal impairment and retinopathy are stronger predictors of overall mortality over a 14-year period.
Answers are grounded in this paper and cite their sources.
Supports renal/retinal/lipid-based risk stratification in type 1 diabetes; leaves open whether targeting these alters outcomes.
We assessed clinical and biochemical predictors of death and/or cardiovascular disease in 147 type 1 diabetes mellitus (DM) patients followed-up for 14 years. At follow-up, 28 of patients (19%) had died, and 25 patients (18%) had developed or died of coronary artery disease (CAD). At baseline, those who died had significantly higher serum creatinine (p=0.001) and urine albumin/creatinine ratio (p=0.016), greater prevalence of retinopathy (p=0.006), lower serum apolipoprotein A1 (p=0.046), and lower daily insulin dose (p=0.024) than those who survived. CAD patients had a longer duration of diabetes (p<0.001), were older at the onset of diabetes and at presentation (p=0.001), and had higher prevalences of retinopathy (p=0.005) and neuropathy (p=0.016). The CAD group also had higher baseline serum creatinine (p=0.02), lower HDL cholesterol (p=0.004) and apolipoprotein A1 (p=0.007) and higher LDL cholesterol (p=0.028) and apolipoprotein B concentrations (p=0.027). Under logistic regression analysis (adjusted for age and sex), baseline urine albumin/creatinine ratio (p=0.003), presence of retinopathy (p=0.004), serum creatinine (p=0.028), and serum urea (p=0.034) were the most powerful predictors of mortality, while duration of diabetes (p<0.0001), baseline HDL cholesterol (p=0.012), serum creatinine (p=0.02), apolipoprotein B (p=0.038), LDL cholesterol (p=0.039), and systolic blood pressure (p=0.055) were the strongest predictors of CAD. These findings emphasize the role of abnormal lipoprotein metabolism in the development of CAD in type 1 DM. Indicators of renal impairment and the presence of retinopathy seem to be of greater importance in predicting overall mortality.
No takes yet. Share an insight, caveat, or question.
Ute Weis (2001) conducted a cohort in type 1 diabetes mellitus (n=147). Clinical and biochemical risk factors (e.g., renal impairment, retinopathy, abnormal lipoproteins) vs. Absence or lower levels of risk factors was evaluated on Death and/or coronary artery disease. Over 14 years, 19% of type 1 diabetes patients died and 18% developed CAD; renal impairment and retinopathy strongly predicted mortality, while abnormal lipoprotein metabolism predicted CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: